DUBLIN–(BUSINESS WIRE)–The “RNAi Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering.

The report predicts the global RNAi therapeutics market to grow with a CAGR of 9% over the forecast period from 2021-2027.

The report on the global RNAi therapeutics market provides qualitative and quantitative analysis for the period from 2019 to 2027. The study on RNAi therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on RNAi therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global RNAi therapeutics market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global RNAi therapeutics market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Collaborations between drug distribution companies and contract research organizations (CROs)
  • The rising deaths of people by cancer
  • Advancing in drug delivery technology which can treat rare and chronic diseases

2) Restraints

  • High investment

3) Opportunities

  • Public institutions are focusing on R&D work on nanotechnology

Segment Covered

The Global RNAi Therapeutics Market by Type

  • Small Interfering RNAs (siRNA)
  • MicroRNA (miRNA)

The Global RNAi Therapeutics Market by Application

  • Genetic Disorders
  • Oncology
  • Neurodegenerative Disorders
  • Infectious Diseases
  • Renal Diseases
  • Others

The Global RNAi Therapeutics Market by Route of Administration

  • Intradermal Injections
  • Pulmonary Delivery
  • Intravenous Injections

The Global RNAi Therapeutics Market by End User

  • Diagnostic Laboratories
  • Research and Academic Laboratories
  • Hospitals

Company Profiles

  • Alnylam Pharmaceuticals, Inc.
  • Sanofi
  • Olix Pharmaceuticals, Inc.
  • Arbutus Biopharma Corporation
  • Silence Therapeutics
  • Rexahn Pharmaceuticals, Inc.
  • Arrowhead Pharmaceuticals, Inc.
  • Quark
  • Others

For more information about this report visit https://www.researchandmarkets.com/r/wwy72r



Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900